| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3861818 | The Journal of Urology | 2013 | 6 Pages |
Abstract
Increased technology penetration is associated with a slightly higher rate of prostate specific antigen testing and no change in the prostate biopsy rate. Collectively, our findings temper concerns that adopting new technology accelerates diagnostic testing for prostate cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Florian R. Schroeck, Samuel R. Kaufman, Bruce L. Jacobs, Ted A. Skolarus, David C. Miller, Alon Z. Weizer, Jeffrey S. Montgomery, John T. Wei, Vahakn B. Shahinian, Brent K. Hollenbeck,